JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (9): 73-78.doi: 10.6040/j.issn.1671-7554.0.2016.1387

Previous Articles     Next Articles

Clinicopathological factors and prognosis between primary central and peripheral lung squamous cell carcinoma

LI Xingkai1, LIU Zhanye2, JIANG Yunfeng3, LI Jun1   

  1. 1. Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University, Jinan 250012, Shandong, China;
    2. Department of Cardiothoracic Surgery, the County Peoples Hospital of Caoxian, Caoxian 274400, Shandong, China;
    3. Department of Thoracic Surgery, the Second Hospital of Shandong University, Jinan 250012, Shandong, China
  • Received:2016-10-26 Online:2017-09-10 Published:2017-09-10

PDF (PC)

416

Abstract: Objective To study the clinicopathological features and the prognosis of primary lung squamous cell carcinoma retrospectively and to provide effective methods for diagnosis and treatment. Methods A retrospective study of the clinical data of 447 primary lung cancer patients from January 2009 to December 2012 was made, including 173 cases of central squamous carcinoma and 274 cases of peripheral lung squamous carcinoma. Students t test, Pearson chi-square test, and parametric test of rank transformation were conducted to identify whether there is a significant difference in the clinicopathological factors between central or peripheral lung squamous cell carcinoma. The survival curve was drawn by Kaplan-Meier method, while different survival curves were compared by Log-rank method. Results The difference of sex, age, pathological features, surgical methods, lymph node metastasis of different tumor diameter and differentiated degree, prognosis of lymph node metastases staging were statistically significant. The 1, 3 and 5 year 山 东 大 学 学 报 (医 学 版)55卷9期 -李星凯,等.原发性中央型和周围型肺鳞癌临床病理学及预后差异 \=-survival rate of central squamous carcinomas was 92.70%, 53.60% and 33.76% respectively, and that of peripheral squamous carcinoma was 97.11%, 70.72% and 40.81%. The prognosis between central and peripheral lung squamous cell carcinoma was significantly different(χ2=9.561, P<0.001). Conclusion The constituent ratio between the male and the female showed statistical difference in peripheral and central lung squamous cell carcinoma. Compared with peripheral lung squamous cell carcinoma, central type had a higher rate of lymph node metastasis, poorer prognosis and youth oriented tendency. In addition, it revealed that the rate of lymph node metastasis was positively related with an increasing size and poorer differentiation of the tumor.

Key words: Squamous cell carcinoma, Lung cancer, Lymph node metastasis, Pathological features, Prognosis

CLC Number: 

  • R734.2
[1] Sereno M, Esteean IR, Zambrana F, et al. Squamous-cell carcinoma of the lungs: is it really so different?[J]. Crit Rev Oncol Hematol, 2012, 84(3): 327-339.
[2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[3] Tse LA, Yu TS, Qiu H, et al. Lung cancer decreased sharply in first 5 years after smoking cessation in Chinese men[J]. J Thorac Oncol, 2011, 6(10): 1670-1676.
[4] Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2013, 143(5 Suppl): e211S-e250S.
[5] Flores RM, Nicastri D, Bauer T, et al. Computed tomography screening for lung cancer: mediastinal lymph node resection in stage IA nonsmall cell lung cancer manifesting as subsolid and solid nodules[J]. Ann Surg, 2017, 265(5):1025-1033.
[6] Saijo T, Ishii G, Nagai K, et al. Differences in clinicopathological and biological features between central-type and peripheral-type squamous cell carcinoma of the lung[J]. Lung Cancer, 2006, 52(1): 37-45.
[7] 王威, 李玉, 高松, 等. 中心型肺鳞癌侵及支气管壁深度与淋巴结转移相关性研究[J]. 中外医疗, 2012, 31(11): 9-10. WANG Wei, LI Yü, GAO Song, et al. Study on the relevancy between the invasion depth of bronchus by hilar type squamous cell carcinoma of lung and the lymph node megastasis[J]. China Foreign Medical Treatment, 2012, 31(11): 9-10.
[8] Shimosato Y, Suzuki A, Hashimoto T, et al. Prognostic implications of fibrotic focus(scar)in small peripheral lung cancers[J]. Am J Surg Pathol, 1980, 4(4): 365-373.
[9] Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6): 1471-1474.
[10] 支修益, 吴一龙, 马胜林, 等. 原发性肺癌诊疗规范(2011年版)[J]. 中国肺癌杂志, 2012, 15(12): 677-688.
[11] Zheng R, Zeng H, Zhang S, et al. National estimates of cancer prevalence in China, 2011[J]. Cancer Lett, 2016, 370(1): 33-38.
[12] 李文兵, 高德伟, 卢文宁, 等. 80岁以上老年非小细胞肺癌切除术后并发症及预后分析[J]. 解放军医学杂志, 2014, 39(10): 823-825. LI Wenbing, GAO Dewei, LU Wenning, et al. Analysis of complications and outcomes after pulmonary resection in patients aged 80 years or over with non-small cell lung cancer[J]. Medical Journal of Chinese Peoples Liberation Army, 2014, 39(10): 823-825.
[13] Takagi H, Matsui M, Umemoto T. Long-term survival of VATS versus open lobectomy[J]. Ann Thorac Surg, 2011, 92(1): 409-410.
[14] Shi W, Zhang W, Sun H, et al. Sleeve lobectomy versus pneumonectomy for non-small cell lung cancer: a meta-analysis[J]. World J Surg Oncol, 2012, 10(1): 1-9.
[15] Varlotto JM, Yao AN, Decamp MM, et al. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival[J]. Int J Radiat Oncol Biol Phys, 2015, 91(4): 765-773.
[16] 王长利, 岳东升, 张真发, 等. 非小细胞肺癌1638例治疗及预后探讨[J]. 中华外科杂志, 2011, 49(7): 618-622. WANG Changli, YUE Dongsheng, ZHANG Zhenfa, et al. Treatment and prognostic analysis of 1638 patients with non-small cell lung cancer[J]. Chinese Journal of Surgery, 2011, 49(7): 618-622.
[17] Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1(less than hilar)non-small cell carcinoma: results of the American college of Surgery Oncology Group Z0030 Trial[J]. J Thorac Cardiovasc Surg, 2011, 141(3):662-670.
[18] 马军亮, 刘伦旭, 蒲强, 等. 肺鳞癌和肺腺癌胸内淋巴结转移相关因素分析[J]. 中国肿瘤临床, 2009, 36(20): 1156-1159. MA Junliang, LIU Lunxu, PU Qiang, et al. Analysis of risk factor for lymph node metastasis in thoracic cavity of squamous cell lung cancer and adenocarcinoma[J]. Chinese Journal of Clinical Oncology, 2009, 36(20):1156-1159.
[19] Flider DB, Port JL, Korst RJ, et al. Tumor size is a determinant of stage distribution in T1 non-small cell lung cancer[J]. Chest, 2005, 128(4): 2304-2308.
[20] Fukui T, Katayama T, Ito S, et al. Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis[J]. Lung Cancer, 2009, 66(3): 309-313.
[21] 李玉, 李厚文, 胡永校. 肺癌淋巴结转移规律的临床研究[J]. 中华胸心血管外科杂志, 2000, 16(1): 10-12. LI Yü, LI Houwen, HU Yongxiao, et al. Clinical study of lymph node metastasis in lung cancer[J]. Chinese Journal of Thoracic and Cardiovascular Surgery, 2000, 16(1): 10-12.
[22] 李军, 李玉, 玉寒冰, 等. 中心型肺癌侵袭深度与淋巴结转移的关系[J]. 中国肺癌杂志, 2009, 12(6): 466.
[23] 朱斌, 柳仓生. 非小细胞肺癌的淋巴结转移相关因素及规律的探讨[J]. 中国肿瘤临床, 2012, 39(15): 1115-1118. ZHU Bin, LIU Cangsheng. Correlation factor and incidence of lymph node metastasis in non-small cell lung cancer[J]. Chinese Journal of Clinical Oncology, 2012, 39(15): 1115-1118.
[1] LI Yinglin, SONG Daoqing, XU Zhonghua. Identification of FKBP11 expression in clear cell renal cell carcinoma using bioinformatics analysis [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 45-51.
[2] MENG Zhaotun, LI Qin, SUN Hui, WU Xinfang, SUN Wenkai, GAO Wei. Correlation between interleukin-18 single nucleotide polymorphism and susceptibility of laryngeal squamous cell carcinoma: a report of 73 cases [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 58-63.
[3] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47-52.
[4] ZONG Shuai, XIAO Dongjie, LIU Hua, JIA Yanfei, MA Xiaoli, LI Huanjie, LI Ping, ZHENG Yan, WANG Yunshan. Expression of CSN5 and its correlation with the prognosis of gastric carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 12-16.
[5] ZENG Haiyan, LI Rui, SUN Xindong, XIE Peng, MENG Xue, FAN Bingjie, LI Wanlong, YUAN Shuanghu. Association analysis of brain metastases after prophylactic cranial irradiation in local disease small cell lung cancer: a bicenter study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 61-66.
[6] SUN Qijing, CHEN Fangfang, LI Chunxiao, ZHANG Caiqing. Clinical value of PNI and HGB in evaluating the prognosis of the middle to late stage non-small cell lung cancer patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(4): 55-59.
[7] LIN Jiaxiang, GUO Zijia, SU Peng, WANG Xiao, GUO Yaxin, WU Xiaojuan, XIANG Lei, ZHOU Zhiqiang, WANG Yan, CUI Xiujie, PAN Aifeng, GUO Chenghao. The role of CIP2A in the transformation of breast ductal epithelium and prognosis of invasive breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 100-106.
[8] CHAI Shude. Current status and technical innovation of radioactive seed brachytherapy in the treatment of bronchial lung cancer in China [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 4-7.
[9] HUO Bin, WANG Lei, WANG Haitao, HUO Xiaodong, CAO Qiang, WANG Lili, ZANG Li, WANG Jinhuan, ZHENG Guanjun, CHAI Shude. Feasibility of radioactive seed implantation in the treatment of lung cancer assisted by template combined with rib drilling technique [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 26-31.
[10] DAI Jianjian, YUAN Bing, ZHANG Ying, LIN Qi, YUAN Yuan, HAN Mingyong. CT-guided percutaneous 125I seed implantation brachytherapy in patients with stage Ⅲ non-small-cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 32-37.
[11] HAN Mingyong, HUO Bin, ZHANG Ying, LIN Qi, DAI Jianjian, XU Ruicai, YANG Qi, GENG Baocheng, ZHENG Guangjun, WANG Haitao, HUO Xiaodong, CHEN Baoming(Reviewed by CHAI Shude, WANG Junjie), 山, 东, 大, 学, 学, 报, (医, 学, 版)55卷2期, -韩明勇,等.CT联合模板引导放射性粒子植入治疗肺癌技术流程, \=-. Technical procedure of template combined with CT-guided radioactive seeds implantation for lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 14-20.
[12] ZHOU Lanlan, PAN Xueyi, GUO Yu. Clinical characteristics and prognosis of 48 patients with mixed phenotype acute leukemia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 79-83.
[13] ZHANG Xiying, ZHAI Chunyan, LI Jingsong, HAN Bo. Expression of EZH2 in Chinese Ewing sarcoma patients and its relationship with clinicopathological parameters and prognosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 84-91.
[14] PENG Yue, FENG Zhen, XIE Hounai, WANG Hui, LI Meng, REN Wangang, LIU Tong, PENG Zhongmin. Surgical treatment for 61 patients with multiple lung lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 42-46.
[15] LIU Huiling, WANG Xingwen, FENG Shaobin, FENG Hong, HAN Junqing. Association between high expression of scavenger receptor class B type I and the prognosis of colon cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 84-89.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd